# Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)

> **NCT03290768** · NA · COMPLETED · sponsor: **Savvysherpa, Inc.** · enrollment: 358 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DEVICE:** Continuous Glucose Monitor (CGM)
- **DEVICE:** Activity Tracker
- **BEHAVIORAL:** Coaching

## Key facts

- **NCT ID:** NCT03290768
- **Lead sponsor:** Savvysherpa, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-13
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03290768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03290768, "Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03290768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*